Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pulmatrix Inc (PULM)

Pulmatrix Inc (PULM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pulmatrix Inc 36 CROSBY DRIVE SUITE 100 BEDFORD MA 01730 USA

www.pulmatrix.com P: 781-357-2333

Description:

Pulmatrix, Inc. is a biopharmaceutical company which is engaged in developing inhaled therapies for serious pulmonary disease. The Company's proprietary product pipeline includes PUR1900, an inhaled anti-fungal for cystic fibrosis, PUR0200, a branded generic for chronic obstructive pulmonary disease which are in different clinical stage. Its technology platform consists of iSPERSE. Pulmatrix, Inc., formerly known as Ruthigen, Inc., is based in Lexington, MA.

Key Statistics

Overview:

Market Capitalization, $K 7,378
Enterprise Value, $K -11,792
Shares Outstanding, K 3,652
Annual Sales, $ 7,300 K
Annual Net Income, $ -14,120 K
Last Quarter Sales, $ 2,200 K
Last Quarter Net Income, $ -2,080 K
EBIT, $ -14,740 K
EBITDA, $ -13,260 K
60-Month Beta 0.92
% of Insider Shareholders 3.61%
% of Institutional Shareholders 11.84%
Float, K 3,520
% Float 96.39%
Short Volume Ratio 0.01

Growth:

1-Year Return -30.82%
3-Year Return -89.37%
5-Year Return -90.98%
5-Year Revenue Growth 4,766.67%
5-Year Earnings Growth 96.11%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.57 on 03/28/24
Latest Earnings Date 05/10/24
Earnings Per Share ttm -3.86
EPS Growth vs. Prev Qtr 44.66%
EPS Growth vs. Prev Year 50.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 03/01/22

PULM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -63.94%
Return-on-Assets % -40.88%
Profit Margin % -193.42%
Debt/Equity 0.00
Price/Sales 1.01
Price/Cash Flow N/A
Price/Book 0.40
Book Value/Share 4.93
Interest Coverage -1.17
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar